TLR7 and lupus nephritis: Administration of TLR7 agonists (imiquimod and R848) can induce lupus nephritis with increased serum ANA levels, especially anti-dsDNA IgG levels, in which enhanced activation of autoreactive B cells might be responsible for the autoantibody production [89].